INTRODUCING KETAMINE-ASSISTED PSYCHOTHERAPY (KAP) INTO MY PRACTICE

Beginning in the first week of January 2025, in a big step forward towards giving my clients

more than talk therapy, I will incorporate Ketamine-Assisted Psychotherapy (KAP) into my

practice. I will do this in collaboration with Journey Clinical Inc., a healthcare company that

specializes in providing evidence-based psychedelic-assisted psychotherapy treatments.

KAP can be a game changer for those clients who feel stuck in their therapy goals and feel that

regular talk therapy, and even certain medications, doesn’t work for them enough to resolve their

issues. It can bring about rapid therapeutic change, help clients with navigating and overcoming

obstacles that cause them stress or impair their functioning.

My role in this arrangement will be limited to referring clients to Journey Clinical who will

evaluate and determine their eligibility for KAP, as well as developing treatment plans. It will

also be my responsibility to oversee dosing and reintegration sessions for clients. So, Journey

Clinical will determine the eligibility of clients to benefit from the KAP, as well as prescribing

the medicine and developing individualized treatment plans.

As an adjunct to talk therapy, KAP is used to afford the clients opportunities for self-exploration

and to enhance therapeutic work. It can be administered in-person, remote, group or self-guided

settings. It also facilitates the client’s ability to work through difficult experiences.

Ketamine itself is considered safe to use but KAP may not be suitable for certain people with

some medical and psychiatric conditions, including those with uncontrolled substance use

disorders. Also, people must be 18 years old or above and be diagnosed with certain conditions

to benefit from the treatment.

Journey Clinical has reported that “87% of our KAP patients report improvement in their

depression and anxiety clinical scores after 2 medical visits.”